| Bioactivity | Brain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research[1]. |
| Invitro | Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 12 h) inhibits the growth of Streptococcus pneumoniae[1].Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 6 d) inhibits HBV replication of HepG2-2.2.15 cells[1].Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 22 h) inhibits the migration of human endothelial cell[1]. Cell Viability Assay[1] Cell Line: |
| Name | Brain Derived Basic Fibroblast Growth Factor (1-24) |
| CAS | 211362-85-5 |
| Shortening | PALPEDGGSGAFPPGHFKDPKRLY |
| Formula | C118H173N31O33 |
| Molar Mass | 2553.82 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dorian Bevec, et al. Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection. WO2009039980A2. |